Trial Profile
Benefit of Elevation of HDL-cholesterol/Triglyceride Lowering on Cardiovascular Outcomes in Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Niacin (Primary)
- Indications Hyperlipidaemia
- Focus Biomarker; Pharmacodynamics
- 15 Aug 2013 New source identified an integrated: ClincialTrials.gov record NCT01921010.
- 15 Aug 2013 New source identified an integrated: ClincialTrials.gov record NCT01921010.
- 04 Apr 2011 Endpoint 'Endothelial-function' has not been met.